146
Participants
Start Date
December 12, 2016
Primary Completion Date
October 20, 2021
Study Completion Date
November 25, 2021
Nintedanib or Placebo; Carboplatin, Paclitaxel
Arm A: Nintedanib: 200mg orally twice daily d 2-21 q 21 days x 6 courses; afterwards daily dosing, until PD Arm B: Placebo: orally twice daily d 2-21 q 21 days x 6 courses; afterwards daily dosing, until PD In both arms: 6 courses of standard carboplatin and paclitaxel: Carboplatin AUC 5 iv every 21 days; Paclitaxel 175mg/m2 iv every 21 days. Both drugs are continued for maximum six courses or until unacceptable toxicity
Cliniques universitaires Saint-Luc, Brussels
Rigshospitalet, Copenhagen
Antwerp University Hospital, Edegem
University Hospitals Leuven, Leuven
Odense Universitetshospital, Odense
Vejle Sygehus, Vejle
Ghent University Hospital, Ghent
Aalborg Universitetshospital, Aalborg
Onze Lieve Vrouwziekenhuis, Aalst
Institut Paoli Calmettes, Marseille
Charité Campus Virchow Clinic, Berlin
Centre François Baclesse, Caen
Universitätsfrauenklinik am Klinikum Südstadt Rostock, Rostock
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Institute Bergonié, Bordeaux
Tampere University Hospital, Tampere
Institut de Cancérologie de l'Ouest, Saint-Herblain
Universitätsklinikum Essen, Essen
Kliniken Essen Mitte, Essen
Universitätsfrauenklinik Mainz, Mainz
Linköping University Hospital, Linköping
Centre Oscar Lambret, Lille
Center of Gynecology and Obstetrics, Frankfurt
Léon Bérard Center, Lyon
Kuopio University Hospital, Kuopio
Hospital Group Diaconesses Croix Saint-Simon, Paris
St. Vincentius-Kliniken gAG Frauenklinik mit Hebammenlehranstalt, Karlsruhe
Universitätsfrauenklinik Ulm, Ulm
ICM (Cancer Institute of Montpellier), Montpellier
Centre Antoine Lacassagne, Nice
Private Hospital Of Côtes D'armor, Plérin
Klinik Chemnitz gGmbH, Chemnitz
University Hospital Carl Gustav Carus Dresden, Dresden
Oslo University Hospital, Oslo
Skåne University Hospital, Lund
Karolinska University Hospital, Stockholm
Uppsala University Hospital, Uppsala
North Eastern German Society of Gynaecological Oncology
OTHER
Belgian Gynaecological Oncology Group
OTHER
ARCAGY/ GINECO GROUP
OTHER
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
OTHER